House Passes Bill Targeting Orphan Drug Exclusivity
By Kevin Stawicki · November 17, 2020, 10:32 PM EST
The U.S. House of Representatives on Tuesday passed a bill that would require drugmakers to prove they don't expect to recoup research and development costs through sales of a new drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login